Related Experiment Video
Updated: Sep 28, 2026

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
Coxsackievirus experimental heart diseases
1Department of Microbiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. gauntt@uthscsa.edu
Insights
Myocarditis, an inflammation of the heart, is often caused by viruses like coxsackievirus B. While acute cases recover, chronic forms can lead to serious heart conditions and death.
Area of Science:
- Cardiology
- Virology
- Immunology
Background:
- Myocarditis is a heart inflammation often triggered by viral infections.
- Coxsackievirus group B (CVB), especially coxsackievirus B3 (CVB3), are significant causes of myocarditis in the U.S.
- Disease factors include gender bias, age, and genetic background, affecting individuals from infancy to adulthood.
Purpose of the Study:
- To discuss the frequency and contributing factors of viral myocarditis.
- To explore the mechanisms behind acute and chronic myocarditis development.
- To understand why current immunosuppressive treatments are ineffective.
Main Methods:
- Review of existing literature on viral myocarditis.
- Analysis of coxsackievirus B (CVB) and coxsackievirus B3 (CVB3) mouse models.
- Detection of viral RNA in heart biopsy specimens using polymerase chain reaction (PCR) assays.
Main Results:
- CVB infections, particularly CVB3, are major causes of myocarditis.
- CVB3-murine models mimic human acute and chronic myocarditis, revealing virus-induced and immune reactions in heart tissue.
- Certain immune responses to CVB3 infection can be detrimental, explaining treatment ineffectiveness.
Conclusions:
- Viral infections, especially CVB, are key causes of myocarditis.
- Understanding the interplay of viral and immune factors is crucial for myocarditis pathogenesis.
- Current treatments focus on supportive care due to complex immune responses.
Abstract:
Many microorganisms, particularly viruses, can cause myocarditis, an inflammatory disease of the heart. The frequency of and major factors that contribute to this disease, including a pronounced gender (male) bias, age and genetic background parameters are discussed, along with signs and symptoms of disease in infants to adults. Individuals with acute disease generally recover without sequelae; the chronic form can develop into idiopathic dilated cardiomyopathy and death can follow. Among viruses most frequently associated with cases in the U.S., the coxsackieviruses group B (CVB) are major etiologic agents. The association between the CVB and disease is based on detection of viral RNA in heart biopsy specimens by polymerase chain reaction assays. Excellent CVB-, particularly coxsackievirus B3 (CVB3)-, mouse models of the disease have identified mechanisms of induction and establishment of chronic myocarditis. CVB3-murine models share many biologic parameters of the acute and chronic diseases in humans, and show that cardiopathologic alterations result from virus-induced and immunologic reactions in heart tissues. Several immune responses to a CVB3 infection that become cardiopathogenic, instead of protective, are discussed in an attempt to explain why immunosuppressive treatments are not effective. Bed rest and supportive therapy are the current treatment for patients with myocarditis.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Rheumatic Heart Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests

